戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 is-specific peptide ligands by phage display biopanning.
2 ovalently bound small peptide discovered via biopanning.
3 mid particles, during library production and biopanning.
4 PYNHNWFAL was selected after three rounds of biopanning.
5   Laminin-1 derivatized plates were used for biopanning.
6 ge (phage) display-mediated antibody/antigen biopanning.
7  moiety, and requires only a single round of biopanning.
8 ng peptide candidates resulting from in vivo biopanning.
9                             Through repeated biopanning, 103 peptidyl sequences were identified, many
10 high-density peptide microarray derived from biopanning a lung cancer phage display library.
11 r consisted of an icosapeptide identified by biopanning a phage display library against Ad5 knob.
12          Here, we achieve spatial control by biopanning a phage library to discover materials that ta
13                From an initial phage display biopanning, a series of peptide ligands for the LDLR was
14 n of affinity probes by successive rounds of biopanning against a biotinylated synthetic peptide comp
15                                  Conversely, biopanning against four mAbs did not yield any frameshif
16                                              Biopanning and rapid analysis of selective interactive l
17 approach to streamline in vivo peptide phage biopanning and to increase its reproducibility and succe
18           However, the current in vivo phage biopanning approaches fail to assess biodistribution of
19  the repertoire, in combination with in vivo biopanning at optimized phage circulation time, we have
20                        After three rounds of biopanning by 1E4 from the phage display library, a mime
21                              Three rounds of biopanning C-34 against the library resulted in striking
22 , cell-specific peptides isolated from phage biopanning can be used for the discovery of cell surface
23 III protein of filamentous phage was used in biopanning experiments against several protein targets.
24 o perform primarily cell-based phage display biopanning experiments to develop new potential recombin
25              This is the first comprehensive biopanning for isolation of high affinity peptidic ligan
26 gainst AFP were isolated from the library by biopanning for the first time.
27              This is the first comprehensive biopanning for the isolation of TM transiting peptidic l
28                          After two rounds of biopanning, >90% of the clones recovered were specifical
29                                              Biopanning has been used extensively in conjunction with
30 er peptide, identified through phage display biopanning, has been used for the first time to induce t
31                                Phage display biopanning identified Gly-Ile-Arg-Leu-Arg-Gly (GIRLRG) a
32 e, we report a pipeline for in vivo promoter biopanning in AAV building on our AAV capsid barcoding t
33                            Here we performed biopanning in non-human primates (NHPs) with an IT injec
34 representation of individual peptides during biopanning in vivo.
35                                           PL biopanning is also unbiased with regard to pathogens or
36       We show that, compared to conventional biopanning methods, microfluidic selection enables more
37 uitable biorecognition element (BRE) through biopanning of a 7-mer phage displayed peptide library.
38 reast with high titer IgG autoantibodies for biopanning of a T7 phage breast cancer cDNA display libr
39 over, we report the first successful in vivo biopanning of AAV capsids by using a new AAV-DJ-derived
40      This high-throughput selection involved biopanning of an ovarian cancer phage display library us
41  demonstrate that peptides obtained from the biopanning of phage display libraries can be readily use
42                 After three or six rounds of biopanning on either Ab, positive phage-displayed Ags re
43                                    By direct biopanning on HUVECs and a second approach involving pre
44     These results demonstrate the utility of biopanning on isolated cells for identifying specific bi
45                            Several rounds of biopanning on NG2 resulted in the specific enrichment of
46        Anti-PSMA Nanobodies were captured by biopanning on PSMA-overexpressing cells.
47        In this study, we conducted cell-free biopanning on recombinant Fn-EDB to identify a short pep
48 quence: AGRGRLVR) was identified by in vitro biopanning on recombinant TNC-C.
49 new approach, termed "protection-linked (PL) biopanning," probes the Ab paratopes of protected vaccin
50       Using a phage display-based whole cell biopanning procedure, we developed two human antibodies
51 se (type V) (TRAP) was used as the bait in a biopanning procedure.
52 ty of cystatins can be used in phage display biopanning procedures to select variants with greater in
53                                            A biopanning process designed to find peptide epitopes spe
54                  Although techniques such as biopanning rely heavily upon the screening of randomized
55                                          One biopanning round followed by NGS selects robust PP-bindi
56                       After three successive biopanning rounds, a panel of six clones with distinct g
57 g recombinant scN proteins were subjected to biopanning selection based on binding affinity to immobi
58 ustrating the potential of phage display and biopanning selection for directed molecular evolution of
59              These results show that in vivo biopanning selection in hypercholesterolemic animals mak
60                                       Papain biopanning selection of phage-displayed soyacystatins re
61                                        After biopanning, several phage-displayed peptides were isolat
62        We used two M13-bacteriophage display biopanning strategies to search for mediators of trans-T
63  M2pep, identified using a subtractive phage biopanning strategy against whole cells.
64               We describe here a new in vivo biopanning strategy in which a human phage single-chain
65   Our data highlight the power of the new PL-biopanning strategy to identify Ab responses with signif
66  the target antigen morphology using a novel biopanning technique that utilizes atomic force microsco
67     The phage library was used in an in vivo biopanning technique to identify non-DNA-binding, kidney
68 nzymatic processing steps into phage display biopanning to expand the biocombinatorial procedure and
69       This demonstrates the potential to use biopanning to generate capture ligands for a large varie
70                                      Through biopanning using gut tissue from larvae of the non-targe
71 erived from affinity-enrichment experiments (biopanning) using a filamentous phage peptide library.
72 s, in vivo bone marrow/cardiac phage display biopanning was performed and led to the identification o
73 btain heart-targeting ligands, phage display biopanning was used to isolate a 20-mer peptide that bin
74                                     After PL biopanning, we analyzed the phagotopes selected for amin
75 ing genetic immunization, phage display, and biopanning, we identified two functional monovalent Abs
76 oE knockout mice was interrogated by in vivo biopanning with a phage-displayed constrained peptidyl l
77 ence, called H10, was previously isolated by biopanning with a random peptide library on filamentous
78               This pipeline combined in vivo biopanning with domain antibody (dAb) phage display, nex
79                                Phage display biopanning with Illumina next-generation sequencing (NGS
80 ge-displayed tumor antigens were enriched by biopanning with normal and then SCCHN-specific serum.
81                                              Biopanning with three different sera led to the cloning